Outcome of treatment of extraocular muscle cysticercosis.
Jethani
Jitendra
J
D015766:Albendazole / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003551:Cysticercosis / Q000175:diagnosis / Q000469:parasitology / Q000628:therapy*; D004359:Drug Therapy, Combination; D015822:Eye Infections, Parasitic / Q000175:diagnosis / Q000469:parasitology / Q000628:therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D015835:Ocular Motility Disorders / Q000175:diagnosis / Q000469:parasitology / Q000628:therapy*; D009801:Oculomotor Muscles / Q000469:parasitology*; D013508:Ophthalmologic Surgical Procedures; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D005938:Glucocorticoids; D011239:Prednisolone; D015766:Albendazole